Cargando…
Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core
Nav1.7 channels are mainly distributed in the peripheral nervous system. Blockade of Nav1.7 channels with small-molecule inhibitors in humans might provide pain relief without affecting the central nervous system. Based on the facts that many reported Nav1.7-selective inhibitors contain aryl sulfona...
Autores principales: | Wang, Jin-tao, Zheng, Yue-ming, Chen, Yue-ting, Gu, Min, Gao, Zhao-bing, Nan, Fa-jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471454/ https://www.ncbi.nlm.nih.gov/pubmed/31316182 http://dx.doi.org/10.1038/s41401-019-0267-z |
Ejemplares similares
-
Mechanism-specific assay design facilitates the discovery of Nav1.7-selective inhibitors
por: Chernov-Rogan, Tania, et al.
Publicado: (2018) -
N-(12-Amino-9,10-dihydro-9,10-ethanoanthracen-11-yl)-4-methylbenzenesulfonamide
por: Mague, Joel T., et al.
Publicado: (2014) -
Nav1.7 and Nav1.8: Diabetes-induced Changes in Primary Sensory Neurons in Rats
por: Lv, Jianlin, et al.
Publicado: (2016) -
A Drug Discovery Approach for an Effective Pain Therapy through Selective Inhibition of Nav1.7
por: Trombetti, Gabriele A., et al.
Publicado: (2022) -
Design, Synthesis and Biochemical Evaluation of Novel Ethanoanthracenes and Related Compounds to Target Burkitt’s Lymphoma
por: Byrne, Andrew J., et al.
Publicado: (2020)